With more beds, new clinics and expanded medical services, the CEO is bolstering the company’s position as a leading healthcare provider in the region.
Wu Yiling, the founder of traditional Chinese medicine producer Shijiazhuang Yiling Pharmaceutical, saw his wealth plunge by $1.1 billion in just one day amid questions over the efficacy of his purported Covid-treatment drugs.
Billionaire Peter Lim—the controlling shareholder of Singapore’s Thomson Medical Group—is said to be keen to invest in Spanish fertility firm IVI-RMA amid booming demand for reproductive medicine across the Asia Pacific region.
A once-in-a-generation explosion in entrepreneurship is taking place as founders bet on themselves in record numbers. MainStreet U.S.A is back in business—and stronger than ever.
Chinese online healthcare stocks plunged more than 10% after a state-run newspaper called for greater supervision of prescription drugs sold on the internet, sparking fears that the government is preparing to introduce new regulations.